Research output per year
Research output per year
Personal profile
Research interests
Immunology is one of the most rapidly growing areas in the biomedical research field. Because no single method is ideal for curing all tumors, multiple disciplines and methods are needed to explore improvements in cancer therapy. Based on my previous findings, I will continue to develop new methods for immunotherapy in MM and related tumors using an interdisciplinary approach. My research will be focused on targeting DKK1 or other novel TAAs for cancer immunotherapy. I will explore the potential of using a novel and universally expressed TAA for immunotherapy of myeloma patients, and further investigate peptide, protein, DNA vaccines or antibody, CAR-T cells for immunotherapy in MM or other cancers.
External positions
Assistant Professor of Cancer Biology Research in Medicine, Weill Cornell Medical College
Jul 1 2019 → …
Research Area Keywords
- Cancer
- Immunobiology & Inflammation
- Molecular Medicine
Free-text keywords
- Immunotherapy
Fingerprint
Dive into the research topics where Jianfei Qian is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of therapeutic monoclonal antibodies against DKK1 peptide-HLA-A2 complex to treat human cancers
Qian, J., Wang, Q., Xiao, L., Xiong, W., Xian, M., Su, P., Yang, M., Zhang, C., Li, Y., Zhong, L., Ganguly, S., Zu, Y. & Yi, Q., Jan 24 2024, In: Journal for immunotherapy of cancer. 12, 1, e008145.Research output: Contribution to journal › Article › peer-review
Open Access -
Erratum: Th9 Cells Represent a Unique Subset of CD4+ T Cells Endowed with the Ability to Eradicate Advanced Tumors (Cancer Cell (2018) 33(6) (1048–1060.e7), (S1535610818302186), (10.1016/j.ccell.2018.05.004))
Lu, Y., Wang, Q., Xue, G., Bi, E., Ma, X., Wang, A., Qian, J., Dong, C. & Yi, Q., Jul 8 2024, In: Cancer Cell. 42, 7, p. 1313-1314 2 p.Research output: Contribution to journal › Comment/debate › peer-review
-
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis
Xian, M., Wang, Q., Xiao, L., Zhong, L., Xiong, W., Ye, L., Su, P., Zhang, C., Li, Y., Orlowski, R. Z., Zhan, F., Ganguly, S., Zu, Y., Qian, J. & Yi, Q., Dec 2024, In: Nature Communications. 15, 1, 5767.Research output: Contribution to journal › Article › peer-review
Open Access -
A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors
Su, P., Xiao, L., Ye, L., Wang, Z., Xiong, W., Wang, Q., Ma, X., Xian, M., Yang, M., Zu, Y., Pingali, S. R., Qian, J. & Yi, Q., May 7 2022, In: Journal of Hematology and Oncology. 15, 1, p. 55 55.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Correction: Enhanced Lipid Accumulation and Metabolism Are Required for the Differentiation and Activation of Tumor-Associated Macrophages
Su, P., Wang, Q., Bi, E., Ma, X., Liu, L., Yang, M., Qian, J. & Yi, Q., Mar 1 2022, In: Cancer research. 82, 5, p. 945 1 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations
Prizes
-
-
Applied Study on Basis of Marek’s Disease Herpesvirus
Qian, Jianfei (Recipient), 1992
Prize: National/international honor
-
Study of oncogenic and nononcogenic strains of Marek’s Herpesvirus
Qian, Jianfei (Recipient), 1998
Prize: National/international honor
-
Vivian L. Smith CCIR Award for Outstanding Young Immunologist
Qian, Jianfei (Recipient), 2007
Prize: Prize (including medals and awards)